Put the Efficacy and Safety of Overactive Bladder Meds Into Perspective

There will be a shift toward fewer Rxs for immediate-release oxybutynin for overactive bladder.

Many payers used to require trying oxybutynin IR before covering any other antimuscarinics...since they tended to cost more.

But costs are coming down as more of these meds go generic.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote